4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-119095
EVP, Head of North America sold 13,677 shares at $32.01 ($437,819)
- EVP, Head of North America acquired 12,030 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-14 | Option exercise 10b5-1 | +12,030 | $6.80 | $81,804 | 13,677 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-14 | Sale 10b5-1 | −13,677 | $32.01 | $437,819 | 0 | D |
| Derivatives | |||||||
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,030 | 46,412 | D | ||
| Open-market sales · 13,677 sh · avg $32.01 · $437,819 | |||||||
Loading xslF345X05/tm2330902-2_4seq1.xml…